France investigates drug trial disaster

@article{Casassus2016FranceID,
  title={France investigates drug trial disaster},
  author={B. Casassus},
  journal={The Lancet},
  year={2016},
  volume={387}
}
Last week’s clinical trial disaster at Rennes, France, has left the country stupefied and eager for an explanation about why the phase 1 study left one particpant dead and fi ve others receiving care in hospital. Three particpants have been said to be facing possible permanent brain damage. A number of details have emerged since Health Minister Marisol Touraine announced last Friday that an “unprecedented [...] accident of exceptional severity” had occurred with a molecule being tested by the… Expand
8 Citations
Phase I studies: a test bench for Italian clinical research
Elevated Brain Fatty Acid Amide Hydrolase Induces Depressive-Like Phenotypes in Rodent Models: A Review
  • PDF
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.
  • R. Tripathi
  • Chemistry, Medicine
  • European journal of medicinal chemistry
  • 2019
  • 12
Quality of phase I clinical drug trials: Influence of organizational management factors
Facilitating access to new therapeutic options through clinical trials: the vision of a regulator to reconcile innovation and safety.
  • 1